Pfam Domains GO Terms
| IL8 |
| negative regulation of natural killer cell chemotaxis |
| helper T cell extravasation |
| negative regulation of lymphocyte chemotaxis |
| CCR2 chemokine receptor binding |
| negative regulation of vascular endothelial cell proliferation |
| astrocyte cell migration |
| positive regulation of NMDA glutamate receptor activity |
| T cell extravasation |
| regulation of natural killer cell chemotaxis |
| negative regulation of glial cell apoptotic process |
| positive regulation of apoptotic cell clearance |
| regulation of apoptotic cell clearance |
| regulation of glial cell apoptotic process |
| PERK-mediated unfolded protein response |
| macrophage chemotaxis |
| negative regulation of lymphocyte migration |
| positive regulation of nitric-oxide synthase biosynthetic process |
| positive regulation of glutamate receptor signaling pathway |
| negative regulation of leukocyte chemotaxis |
| macrophage migration |
| positive regulation of endothelial cell apoptotic process |
| regulation of nitric-oxide synthase biosynthetic process |
| regulation of vascular endothelial cell proliferation |
| positive regulation of calcium ion import |
| eosinophil chemotaxis |
| eosinophil migration |
| regulation of lymphocyte chemotaxis |
| T cell migration |
| viral genome replication |
| CCR chemokine receptor binding |
| positive regulation of synaptic transmission, glutamatergic |
| positive regulation of epithelial cell apoptotic process |
| positive regulation of signaling receptor activity |
| lipopolysaccharide-mediated signaling pathway |
| ER-nucleus signaling pathway |
| regulation of NMDA receptor activity |
| glial cell migration |
| negative regulation of endothelial cell proliferation |
| receptor signaling pathway via JAK-STAT |
| protein kinase B signaling |
| regulation of calcium ion import |
| receptor signaling pathway via STAT |
| cellular extravasation |
| monocyte chemotaxis |
| negative regulation of leukocyte migration |
| lymphocyte chemotaxis |
| mononuclear cell migration |
| chemokine activity |
| regulation of endothelial cell apoptotic process |
| negative regulation of chemotaxis |
| regulation of lymphocyte migration |
| regulation of glutamate receptor signaling pathway |
| lymphocyte migration |
| positive regulation of phagocytosis |
| regulation of synaptic transmission, glutamatergic |
| positive regulation of cation channel activity |
| sensory perception of pain |
| regulation of neurotransmitter receptor activity |
| regulation of epithelial cell apoptotic process |
| chemokine-mediated signaling pathway |
| cell |
| neutrophil chemotaxis |
| granulocyte chemotaxis |
| cellular response to chemokine |
| response to chemokine |
| neutrophil migration |
| regulation of phagocytosis |
| granulocyte migration |
| negative regulation of G1/S transition of mitotic cell cycle |
| positive regulation of ion transmembrane transporter activity |
| endoplasmic reticulum unfolded protein response |
| negative regulation of cell cycle G1/S phase transition |
| cellular response to fibroblast growth factor stimulus |
| positive regulation of transporter activity |
| regulation of leukocyte chemotaxis |
| response to fibroblast growth factor |
| positive regulation of calcium ion transport |
| negative regulation of epithelial cell proliferation |
| cellular response to unfolded protein |
| myeloid leukocyte migration |
| regulation of endothelial cell proliferation |
| positive regulation of cation transmembrane transport |
| negative regulation of neuron apoptotic process |
| leukocyte chemotaxis |
| cellular response to topologically incorrect protein |
| regulation of G1/S transition of mitotic cell cycle |
| positive regulation of synaptic transmission |
| regulation of cell shape |
| positive regulation of ion transmembrane transport |
| cellular response to interferon-gamma |
| response to unfolded protein |
| regulation of cell cycle G1/S phase transition |
| regulation of cation channel activity |
| regulation of signaling receptor activity |
| cellular response to interleukin-1 |
| response to interferon-gamma |
| cellular response to lipopolysaccharide |
| response to topologically incorrect protein |
| cellular response to molecule of bacterial origin |
| regulation of leukocyte migration |
| response to interleukin-1 |
| viral life cycle |
| positive regulation of T cell activation |
| positive regulation of transmembrane transport |
| negative regulation of neuron death |
| regulation of neuron apoptotic process |
| cell chemotaxis |
| positive regulation of ERK1 and ERK2 cascade |
| regulation of chemotaxis |
| negative regulation of mitotic cell cycle phase transition |
| gliogenesis |
| cellular response to biotic stimulus |
| positive regulation of leukocyte cell-cell adhesion |
| negative regulation of cell cycle phase transition |
| protein kinase activity |
| cellular response to tumor necrosis factor |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| regulation of calcium ion transport |
| positive regulation of cell-cell adhesion |
| response to endoplasmic reticulum stress |
| regulation of ion transmembrane transporter activity |
| negative regulation of cell migration |
| response to tumor necrosis factor |
| regulation of transmembrane transporter activity |
| negative regulation of cell motility |
| positive regulation of ion transport |
| regulation of transporter activity |
| regulation of ERK1 and ERK2 cascade |
| regulation of leukocyte cell-cell adhesion |
| negative regulation of mitotic cell cycle |
| negative regulation of cellular component movement |
| regulation of neuron death |
| response to lipopolysaccharide |
| angiogenesis |
| regulation of T cell activation |
| negative regulation of locomotion |
| negative regulation of cell cycle process |
| response to molecule of bacterial origin |
| regulation of cation transmembrane transport |
| regulation of epithelial cell proliferation |
| signaling receptor binding |
| humoral immune response |
| positive regulation of lymphocyte activation |
| negative regulation of response to external stimulus |
| MAPK cascade |
| leukocyte migration |
| regulation of metal ion transport |
| signal transduction by protein phosphorylation |
| regulation of cell-cell adhesion |
| positive regulation of cell adhesion |
| positive regulation of leukocyte activation |
| blood vessel morphogenesis |
| regulation of mitotic cell cycle phase transition |
| positive regulation of GTPase activity |
| positive regulation of cell activation |
| negative regulation of immune system process |
| modulation of chemical synaptic transmission |
| regulation of trans-synaptic signaling |
| regulation of cell cycle phase transition |
| regulation of ion transmembrane transport |
| regulation of GTPase activity |
| blood vessel development |
| regulation of cell morphogenesis |
| inflammatory response |
| cellular response to growth factor stimulus |
| vasculature development |
| regulation of lymphocyte activation |
| cardiovascular system development |
| cellular response to lipid |
| response to growth factor |
| cellular response to organic cyclic compound |
| positive regulation of MAPK cascade |
| regulation of vesicle-mediated transport |
| chemotaxis |
| taxis |
| regulation of transmembrane transport |
| negative regulation of cell cycle |
| regulation of leukocyte activation |
| regulation of mitotic cell cycle |
| regulation of cell activation |
| positive regulation of apoptotic process |
| positive regulation of programmed cell death |
| tube morphogenesis |
| cytokine-mediated signaling pathway |
| negative regulation of cell population proliferation |
| regulation of cell adhesion |
| response to bacterium |
| positive regulation of cell death |
| regulation of ion transport |
| viral process |
| regulation of MAPK cascade |
| regulation of cell cycle process |
| innate immune response |
| positive regulation of hydrolase activity |
| symbiotic process |
| interspecies interaction between organisms |
| tube development |
| regulation of cell migration |
| response to lipid |
| circulatory system development |
| negative regulation of apoptotic process |
| anatomical structure formation involved in morphogenesis |
| cellular homeostasis |
| negative regulation of programmed cell death |
| regulation of cell motility |
| response to organic cyclic compound |
| cell adhesion |
| biological adhesion |
| defense response to other organism |
| animal organ morphogenesis |
| cell migration |
| sensory perception |
| protein phosphorylation |
| regulation of locomotion |
| positive regulation of transport |
| negative regulation of cell death |
| regulation of cellular component movement |
| cellular response to cytokine stimulus |
| positive regulation of protein phosphorylation |
| positive regulation of intracellular signal transduction |
| cellular response to oxygen-containing compound |
| positive regulation of phosphorylation |
| regulation of anatomical structure morphogenesis |
| cell motility |
| localization of cell |
| regulation of response to external stimulus |
| response to cytokine |
| cytoskeleton organization |
| positive regulation of phosphorus metabolic process |
| positive regulation of phosphate metabolic process |
| positive regulation of immune system process |
| regulation of cell cycle |
| cellular response to endogenous stimulus |
| positive regulation of protein modification process |
| regulation of hydrolase activity |
| phosphorylation |
| response to other organism |
| response to external biotic stimulus |
| locomotion |
| G protein-coupled receptor signaling pathway |
| response to biotic stimulus |
| defense response |
| nervous system process |
| positive regulation of catalytic activity |
| regulation of protein phosphorylation |
| response to endogenous stimulus |
| regulation of apoptotic process |
| movement of cell or subcellular component |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| regulation of phosphorylation |
| extracellular space |
| positive regulation of cellular protein metabolic process |
| regulation of cell population proliferation |
| negative regulation of response to stimulus |
| neurogenesis |
| homeostatic process |
| regulation of immune system process |
| positive regulation of signal transduction |
| regulation of cell death |
| intracellular signal transduction |
| cellular response to stress |
| positive regulation of protein metabolic process |
| positive regulation of molecular function |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| regulation of protein modification process |
| regulation of transport |
| immune response |
| positive regulation of macromolecule biosynthetic process |
| extracellular region |
| system process |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Trientine 500μM R08 exp534 | -1.95 |
| UM0125461 0.74μM R02 exp84 | -1.79 |
| UM0011500 10μM R05 exp246 | -1.71 |
| Diepoxybutane 3μM R07 exp354 | 2.03 |
| Cidofovir 10μM R07 exp345 | 2.22 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution